{
    "code": "02023468",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023468",
    "time": "2016-11-18 20:21:57",
    "許可證字號": "衛署藥輸字第023468號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/06\/18",
    "發證日期": "91\/06\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202346805",
    "中文品名": "應治凝注射液 0.75 公絲\/公撮",
    "英文品名": "INTEGRILIN INJECTION 0.75MG\/ML",
    "適應症": "預防不穩定性心絞痛及非Q 波心肌梗塞病人的惡化。經皮腔間冠狀動脈血管擴張術的輔助治療，以預防突發性動脈血管閉塞及相關的急性缺血併發症。",
    "劑型": "270注射劑",
    "包裝": "100公撮小瓶 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "EPTIFIBATIDE"
    ],
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F250402000  PATHEON ITALIA S.P.A.",
        "製造廠廠址": "VIA MOROLENSE 87, 03013 FERENTINO, ITALY",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F050006000  SCHERING-PLOUGH LABO N.V.",
            "製造廠廠址": "INDUSTRIEPARK 30, B-2220 HEIST-OP-DEN-BERG, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200050400",
            "成分名稱": "EPTIFIBATIDE",
            "含量描述": "",
            "含量": "0.7500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "應治凝 注射液_仿單-102-12-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=008&Type=9"
        },
        {
            "title": "0202346802___20110815.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=007&Type=9"
        },
        {
            "title": "0202346801___20110815.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=006&Type=9"
        },
        {
            "title": "020234680005___20110301.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=005&Type=9"
        },
        {
            "title": "020234680004___20110301.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=004&Type=9"
        },
        {
            "title": "020234680003___20110301.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=003&Type=9"
        },
        {
            "title": "020234680002___20110301.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=002&Type=9"
        },
        {
            "title": "020234680001___20110301.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=001&Type=9"
        },
        {
            "title": "Integrilin Injection 0.75mgml Label-104-09-22(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=013&Type=8"
        },
        {
            "title": "Integrilin Injection 0.75mgml Carton-104-09-22(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=012&Type=8"
        },
        {
            "title": "Integrilin 0___20110301.75 mg ENG label.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=003&Type=8"
        },
        {
            "title": "Integrilin 0___20110301.75 mg CH label.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=002&Type=8"
        },
        {
            "title": "Integrilin 0___20110301.75 mg carton.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023468&Seq=001&Type=8"
        }
    ]
}